Unlock AI-driven, actionable R&D insights for your next breakthrough.

Borosilicate Glass: Comprehensive Analysis Of Composition, Properties, And Advanced Applications

JUN 16, 202649 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Borosilicate glass represents a critical class of silicate materials characterized by the incorporation of boron trioxide (B₂O₃) into the silica network, yielding exceptional thermal shock resistance, chemical durability, and optical clarity. Widely employed in pharmaceutical packaging, laboratory equipment, automotive glazing, and microfluidic devices, borosilicate glass compositions are engineered to meet stringent performance criteria including hydrolytic stability (Class 1), low coefficient of thermal expansion (CTE), and high mechanical strength. This article provides an in-depth examination of borosilicate glass formulations, synthesis methodologies, property optimization strategies, and emerging applications, drawing upon recent patent literature and industrial best practices to guide advanced R&D efforts.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Composition And Structural Characteristics Of Borosilicate Glass

Borosilicate glass is defined by its multi-component oxide composition, wherein silicon dioxide (SiO₂) forms the primary network former, and boron trioxide (B₂O₃) acts as both a network former and flux, reducing melting temperature and modifying thermal expansion behavior 1,2. Typical formulations contain 60–85 wt% SiO₂, 5–20 wt% B₂O₃, and 0–17 wt% Al₂O₃, with alkali oxides (Li₂O, Na₂O, K₂O) and alkaline earth oxides (MgO, CaO, SrO, BaO) introduced to tailor viscosity, chemical resistance, and mechanical properties 2,5,6.

The structural role of boron is complex: at low alkali content, boron predominantly exists in trigonal BO₃ units, which create non-bridging oxygen sites and lower glass transition temperature (Tg); with increasing alkali oxide concentration, boron converts to tetrahedral BO₄⁻ units charge-balanced by alkali cations, enhancing network connectivity and chemical durability 2,15. Aluminum oxide (Al₂O₃) further stabilizes the network by forming AlO₄⁻ tetrahedra, improving hydrolytic resistance and mechanical strength, particularly in pharmaceutical-grade compositions 5,6,18.

Recent formulations emphasize precise control of the molar ratio [Al₂O₃]/([SiO₂]+[B₂O₃]) ≤ 0.015 to optimize basicity (≥0.485) and achieve superior heat-shielding properties in automotive glazing applications 14,20. Iron oxide (Fe₂O₃) at 0.10–1.0 wt% is intentionally added to modulate near-infrared (NIR) absorption, with transmittance at 900–1300 nm reduced by 5–15% upon thermal bending, enhancing solar control without compromising visible light transmission (≥78% at 500 nm for 2 mm thickness) 8,12,14.

Key compositional parameters include:

  • SiO₂ content: 65–85 wt% ensures structural integrity and chemical inertness 1,5,13.
  • B₂O₃ content: 5–20 wt% balances thermal expansion (CTE 30–55×10⁻⁷/°C) and processing viscosity 2,15.
  • Al₂O₃ content: 0–17 wt% enhances hydrolytic stability (ISO 719 Class 1) and prevents devitrification during sintering 2,5,18.
  • Alkali oxides (R₂O): 2–10 wt% (Li₂O+Na₂O+K₂O) adjust melting point and ion-exchange strengthening potential 5,6,13.
  • Alkaline earth oxides: 0–12 wt% (MgO+CaO+SrO+BaO) modify CTE and improve melt homogeneity 1,4,14.

Advanced compositions for electronic substrates achieve elastic modulus >82 GPa, strain point ≥690°C, and density <2.55 g/cm³ by optimizing SiO₂ (59–69 mol%), B₂O₃ (5–11.5 mol%), Al₂O₃ (8–15.5 mol%), and incorporating Y₂O₃ (0.1–0.6 mol%) and ZrO₂ (0.5–1.5 mol%) to enhance rigidity and thermal stability 19.

Thermal And Mechanical Properties: Quantitative Performance Metrics

Borosilicate glass exhibits a coefficient of thermal expansion (CTE) in the range of 30–55×10⁻⁷/°C (20–300°C), significantly lower than soda-lime glass (90×10⁻⁷/°C), conferring exceptional thermal shock resistance 2,15,19. This property is critical for applications involving rapid temperature cycling, such as laboratory glassware (withstanding ΔT ≥150°C) and cookware 1,18.

Mechanical strength is quantified by elastic modulus (E), which ranges from 60 to 82 GPa depending on composition. Alkali-free formulations optimized for display substrates achieve E >82 GPa, strain point Ts ≥690°C, and Vickers hardness 550–600 HV, meeting the rigidity requirements for large-format (Gen 8+) TFT-LCD and OLED panels 19. Ion-exchange strengthening (immersion in molten KNO₃ at 400–500°C for 4–16 hours) induces compressive stress layers (CS 600–900 MPa, depth of layer DOL 30–80 μm), increasing flexural strength from ~70 MPa (annealed) to >200 MPa (strengthened) 16,18.

Thermal stability is characterized by glass transition temperature (Tg 500–560°C), softening point (Ts 700–820°C), and annealing point (Ta 550–600°C). High-temperature viscosity at 1300°C (log η ≈ 3–4 dPa·s) facilitates tube drawing and pressing operations, while viscosity at Tg (log η ≈ 12 dPa·s) defines the upper service temperature for dimensional stability 1,9,18.

Key thermal and mechanical data:

  • CTE (20–300°C): 30–55×10⁻⁷/°C 2,15,19
  • Elastic modulus: 60–82 GPa 19
  • Strain point: 550–690°C 18,19
  • Density: 2.23–2.55 g/cm³ 19
  • Vickers hardness: 500–600 HV 19
  • Flexural strength (ion-exchanged): 150–250 MPa 16,18

Thermal shock resistance is quantified by the parameter R = σ·(1−ν)/(E·α), where σ is tensile strength, ν is Poisson's ratio, E is elastic modulus, and α is CTE. Borosilicate glass achieves R values 3–5× higher than soda-lime glass, enabling survival of quenching from 200°C into ice water without fracture 1,18.

Chemical Durability And Hydrolytic Stability: ISO And ASTM Standards

Borosilicate glass is renowned for its superior chemical resistance, classified as Hydrolytic Class 1 (ISO 719), Acid Class 1 (ISO 1776), and Alkali Class 2 (ISO 695) 5,6,18. Hydrolytic stability is measured by the release of Na₂O equivalents (μg/g glass) after autoclaving powdered glass (300–500 μm) in water at 121°C for 60 minutes; Class 1 requires ≤62 μg/g 5,18.

Pharmaceutical-grade formulations (e.g., Type I borosilicate per USP <660>) contain 70.5–76.5 wt% SiO₂, 6.5–11.5 wt% B₂O₃, 4–8 wt% Al₂O₃, and 5.5–10.5 wt% total alkali oxides, achieving hydrolytic resistance suitable for parenteral drug packaging (vials, ampoules, syringes) 5,6,18. The absence of BaO, As₂O₃, and Sb₂O₃ ensures compliance with pharmaceutical and environmental regulations (REACH, FDA 21 CFR 177.1010) 5,18.

Acid resistance (Class 1) is verified by weight loss <0.7 mg/dm² after 6-hour immersion in 6 M HCl at 100°C (ISO 1776). Alkali resistance (Class 2) permits weight loss <75 mg/dm² after 3-hour exposure to 1 M NaOH + 0.5 M Na₂CO₃ at 100°C (ISO 695); incorporation of 0.5 wt% ZrO₂ upgrades alkali resistance to Class 1 (<35 mg/dm²) 18.

Chemical durability mechanisms include:

  • Low alkali leaching: High SiO₂ and Al₂O₃ content minimizes ion-exchange with aqueous solutions 5,18.
  • Boron retention: Tetrahedral BO₄⁻ units are more stable than trigonal BO₃ in aqueous environments 2,15.
  • Surface passivation: Formation of hydrated silica gel layer (thickness 10–50 nm) inhibits further dissolution 18.

For biopharmaceutical applications, delamination resistance is critical. Formulations with <0.02 wt% chemical oxygen demand (COD) in silicate precursors and controlled sulfate/nitrate refining suppress formation of alkali-rich surface layers that cause flaking upon autoclaving 3,9.

Synthesis And Manufacturing Processes: Batch Formulation To Forming

Borosilicate glass production involves batch preparation, melting, refining, homogenization, forming, and annealing. Raw materials include high-purity quartz sand (SiO₂), boric acid (H₃BO₃) or borax (Na₂B₄O₇·10H₂O), aluminum hydroxide (Al(OH)₃), and alkali/alkaline earth carbonates or nitrates 1,3,9,10.

Batch Formulation And Melting

Batch components are weighed to achieve target oxide composition, with typical batch-to-glass conversion efficiency 85–90%. Refining agents include sulfates (0.1–0.8 wt% SO₃) 1, nitrates (0.5–2 wt%) 3,9, or halides (Cl⁻ 1.5–2.5 wt%) 16 to eliminate dissolved gases (CO₂, H₂O, O₂) and reduce bubble content to <0.1 bubbles/kg.

Melting occurs in platinum-lined or refractory-lined furnaces at 1400–1650°C for 12–24 hours. High-purity formulations for pharmaceutical tubing require silicate precursors with COD <200 ppm (<0.02 wt%) to prevent organic contamination and delamination 3,9. Controlled atmosphere melting (reducing or oxidizing) adjusts redox state (Fe²⁺/Fe³⁺ ratio) to optimize UV absorption and color 8,12,13.

Refining And Homogenization

Refining at 1450–1550°C for 4–8 hours promotes bubble rise and coalescence. Sulfate refining releases SO₂ gas, while nitrate refining generates O₂; halide refining (Cl⁻, Br⁻) lowers surface tension, facilitating bubble removal 1,3. Homogenization via stirring or bubbling ensures compositional uniformity (±0.5 wt% oxide variation) and eliminates striae 1,9.

Forming Techniques

  • Tube drawing: Danner or Vello process for pharmaceutical tubing (OD 5–50 mm, wall thickness 0.5–3 mm) at 1050–1150°C 9,18.
  • Float process: Continuous ribbon production (thickness 2–12 mm) on molten tin bath at 1050–1100°C for architectural and automotive glazing 12,14.
  • Overflow fusion (down-draw): Precision flat glass (thickness 0.3–3 mm, flatness <50 μm/m) for display substrates 19.
  • Pressing and blowing: Laboratory glassware, bottles, and complex shapes at 1000–1100°C 1,10.

Annealing And Strengthening

Annealing at Ta ±20°C (550–600°C) for 1–4 hours relieves residual stress (<10 MPa birefringence). Ion-exchange strengthening in molten KNO₃ (400–500°C, 4–16 hours) replaces surface Na⁺ with K⁺, inducing compressive stress (CS 600–900 MPa, DOL 30–80 μm) and increasing impact resistance 3–5× 16,18.

Thermal tempering (heating to 650–700°C, rapid air quenching) generates surface compression (CS 80–120 MPa) but is less effective than ion-exchange due to low CTE 18.

Advanced Applications: Pharmaceutical, Automotive, And Microfluidic Systems

Pharmaceutical Packaging: Vials, Ampoules, And Syringes

Type I borosilicate glass (USP <660>, Ph. Eur. 3.2.1) is the gold standard for parenteral drug containers, offering Hydrolytic Class 1 stability, minimal ion leaching (<1 ppm Na⁺, <0.1 ppm Al³⁺ after 121°C autoclaving), and compatibility with biologics (monoclonal antibodies, vaccines, gene therapies) 5,6,18. Formulations contain 70.5–76.5 wt% SiO₂, 6.5–11.5 wt% B₂O₃, 4–8 wt% Al₂O₃, and are free of BaO, As₂O₃, Sb₂O₃ to meet FDA and EMA requirements 5,18.

Delamination resistance is achieved by using silicate precursors with COD <200 ppm and optimizing alkali oxide ratios (Li₂O 0.5–2 wt%, Na₂O 4.5–9 wt%) to prevent phase separation during autoclaving 3,9. Surface treatment with ammonium sulfate or silane coupling agents enhances protein adsorption resistance and reduces particulate shedding 17.

Case Study: Enhanced Delamination Resistance In Prefilled Syringes — Pharmaceutical

A leading pharmaceutical glass manufacturer implemented low-COD silicate precursors (<0.02 wt%) and sulfate refining (0.3 wt% SO₃) to produce 1 mL prefilled syringes with delamination rate <0.01% after 100 autoclave cycles (121°C, 20 min), meeting ISO 11040-4 requirements for combination products 3,9.

Automotive Glazing: Heat-Shielding And Laminated Glass

Borosilicate glass with controlled Fe₂O₃ content (0.10–1.0 wt%) and optimized basicity (≥0.485) achieves selective NIR absorption, reducing solar heat gain by 15–25% compared to standard soda-lime glass 8,12,14. Transmittance at 900–1300 nm decreases from Tb (as-formed) to Ta (after thermal bending at T₁₂ ≥10¹² dPa·s), with ΔT = Tb − Ta >0, enhancing cabin comfort and reducing HVAC energy consumption by 10–15% 8,12.

Laminated structures (borosilicate outer ply 2 mm / PVB interlayer 0.76 mm / soda-lime inner ply 2 mm) provide impact resistance (ECE R43), UV blocking (>99% at <380 nm), and acoustic damping (STC 35–

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
SCHOTT AGPharmaceutical primary packaging including vials, ampoules, and prefilled syringes for biologics, vaccines, and high-efficacy drug solutions requiring superior chemical resistance and delamination prevention.FIOLAX Type I Pharmaceutical TubingHydrolytic Class 1 stability with sulfate refining (0.01-0.8 wt% SO₃), achieving <62 μg/g Na₂O equivalent leaching after autoclaving, meeting USP <660> and ISO 719 standards for parenteral drug packaging.
NIPPON ELECTRIC GLASS CO. LTD.High-purity pharmaceutical containers for chemically unstable and highly reactive drug solutions, including prefilled syringes and vials for combination products in biopharmaceutical applications.Pharmaceutical Borosilicate Glass TubingDelamination-resistant formulation using silicate precursors with COD <200 ppm (<0.02 wt%) and nitrate refining, achieving <0.01% delamination rate after 100 autoclave cycles at 121°C, compliant with ISO 11040-4.
AGC Inc.Automotive windshields and side windows requiring solar control and thermal comfort, reducing HVAC energy consumption by 10-15% in passenger vehicles while meeting ECE R43 safety standards.Automotive Heat-Shielding GlazingControlled Fe₂O₃ content (0.10-1.0 wt%) and optimized basicity (≥0.485) achieve 15-25% reduction in solar heat gain with NIR transmittance decrease of 5-15% after thermal bending, while maintaining visible light transmission ≥78% at 500 nm for 2 mm thickness.
Corning IncorporatedLab-on-a-chip platforms, microfluidic channels, and biosensor substrates requiring precise sintering, chemical durability, and compatibility with biological reagents in diagnostic and analytical applications.Microfluidic Device SubstratesDevitrification-resistant composition (60-74 wt% SiO₂, 9-25 wt% B₂O₃, 7-17 wt% Al₂O₃) with CTE 30-55×10⁻⁷/°C enables sintering at 700-800°C without crystal formation or inhibitor oxide addition, maintaining mechanical strength and dimensional stability.
CNBM RESEARCH INSTITUTE FOR ADVANCED GLASS MATERIALS GROUP CO. LTD.Large-format (Gen 8+) display substrates for TFT-LCD and OLED panels requiring high dimensional stability, thermal resistance, and mechanical strength for precision electronic device manufacturing.High-Generation TFT-LCD/OLED SubstratesAlkali-free composition achieving elastic modulus >82 GPa, strain point ≥690°C, density <2.55 g/cm³, and CTE 35-39×10⁻⁷/°C through optimized SiO₂ (59-69 mol%), B₂O₃ (5-11.5 mol%), Al₂O₃ (8-15.5 mol%), with Y₂O₃ and ZrO₂ additions for enhanced rigidity.
Reference
  • Method for producing borosilicate glasses
    PatentInactiveEP1266872A1
    View detail
  • Borosilicate glass compositions and uses thereof
    PatentInactiveUS7596968B2
    View detail
  • Production method for borosilicate glass
    PatentWO2017110906A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png